Search

Your search keyword '"Andreas Gaumann"' showing total 86 results

Search Constraints

Start Over You searched for: Author "Andreas Gaumann" Remove constraint Author: "Andreas Gaumann"
86 results on '"Andreas Gaumann"'

Search Results

1. Expression of the plasma membrane citrate carrier (pmCiC) in human cancerous tissues—correlation with tumour aggressiveness

2. A new promising oncogenic target (p.C382R) for treatment with pemigatinib in patients with cholangiocarcinoma

3. Significant impact of circulating tumour DNA mutations on survival in metastatic breast cancer patients

4. Extracellular Citrate Fuels Cancer Cell Metabolism and Growth

5. Potential Use of Gluconate in Cancer Therapy

6. Potential Involvement of Extracellular Citrate in Brain Tumor Progression

7. Supplementary Table 1, Figures 1 - 4 from Dietary Immunosuppressants Do Not Enhance UV-Induced Skin Carcinogenesis, and Reveal Discordance between p53-Mutant Early Clones and Carcinomas

8. Supplementary Figure S2 from Extracellular Citrate Affects Critical Elements of Cancer Cell Metabolism and Supports Cancer Development In Vivo

9. Supplementary Fig. S3 from Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes

10. Data from Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes

11. Supplementary Table S1 from Extracellular Citrate Affects Critical Elements of Cancer Cell Metabolism and Supports Cancer Development In Vivo

12. Supplementary Figure 1 from Extracellular Citrate Affects Critical Elements of Cancer Cell Metabolism and Supports Cancer Development In Vivo

13. Data from Extracellular Citrate Affects Critical Elements of Cancer Cell Metabolism and Supports Cancer Development In Vivo

14. Antitumor Activity of Larotrectinib in Esophageal Carcinoma with NTRK Gene Amplification

15. Extracellular citrate and metabolic adaptations of cancer cells

16. Landscape of Biomarkers and Actionable Gene Alterations in Adenocarcinoma of GEJ and Stomach-A Real World Data Analysis

17. Pediatric Maxillary Osteomyelitis: A Case Report of a Rare Entity

18. Significant impact of circulating tumour DNA mutations on survival in metastatic breast cancer patients

19. Real world data analysis of next generation sequencing and protein expression in metastatic breast cancer patients

20. Extracellular citrate fuels cancer cell metabolism and growth

21. Molecular similarities and differences from human pulmonary fibrosis and corresponding mouse model: MALDI imaging mass spectrometry in comparative medicine

22. Mutational frequencies of CD79B and MYD88 vary greatly between primary testicular DLBCL and gastrointestinal DLBCL

23. Real-world data analysis of next generation sequencing and protein expression in metastatic breast cancer patients

24. Extracellular citrate affects critical elements of cancer cell metabolism and supports cancer development in vivo

25. Receptor tyrosine kinase inhibitors: Are they real tumor killers?

26. Insufficient Angiogenesis: Cause of Abnormally Thin Endometrium in Subfertile Patients?

27. The inhibition of tyrosine kinase receptor signalling in leiomyosarcoma cells using the small molecule kinase inhibitor PTK787/ZK222584 (Vatalanib®)

28. No mutations of FGFR3 in normal urothelium in the vicinity of urothelial carcinoma of the bladder harbouring activating FGFR3 mutations in patients with bladder cancer

30. Nuclear karyopherin α2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity

31. Spatiotemporal Expression of flk-1 in Pulmonary Epithelial Cells during Lung Development

32. Primary and metastatic high-grade pleomorphic sarcoma/malignant fibrous histiocytoma of the gastrointestinal tract: an approach to the differential diagnosis in a series of five cases with emphasis on myofibroblastic differentiation

33. Low-grade abdominopelvic sarcoma with myofibroblastic features (low-grade myofibroblastic sarcoma): clinicopathological, immunohistochemical, molecular genetic and ultrastructural study of two cases with literature review

34. Intraepitheliale Neoplasien (PanIN) und intraduktale papillär-muzinöse Neoplasien (IPMN) des Pankreas als Vorläufer des Pankreaskarzinoms

35. Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model

36. Analysis of vascular gene expression in arthritic synovium by laser-mediated microdissection

37. Lactotrophs: The new and major source for VEGF secretion and the influence of ECM on rat pituitary function in�vitro

38. Shift in prevalence of HPV types in cervical cytology specimens in the era of HPV vaccination

39. Development of De Novo Cancer in p53 Knock-Out Mice is Dependent on the Type of Long-Term Immunosuppression Used

40. Haemangiopericytoma of the thyroid gland in combination with Hashimoto?s disease

41. Impaired brain angiogenesis and neuronal apoptosis induced by conditional homozygous inactivation of vascular endothelial growth factor

42. Circulating Vascular Progenitor Cells Do Not Contribute to Compensatory Lung Growth

43. Expression of drug resistance related proteins in sarcomas of the pulmonary artery and poorly differentiated leiomyosarcomas of other origin

44. Increased angiogenesis and FGFR protein expression indicate a favourable prognosis in bladder cancer

45. Expression of apoptosis-related proteins, p53, and DNA fragmentation in sarcomas of the pulmonary artery

46. Encapsulated lipomas of the tongue in benign symmetric lipomatosis

47. Correlation of endoanal sonography with cross-sectional anatomy of the anal sphincter

48. The Vascular Anatomy of the Inner Anterior Abdominal Wall with Special Reference to the Transversus and Rectus Abdominis Musculoperitoneal (TRAMP) Composite Flap for Vaginal Reconstruction

49. Dietary immunosuppressants do not enhance UV-induced skin carcinogenesis, and reveal discordance between p53-mutant early clones and carcinomas

50. p38 MAP Kinase—a molecular switch between VEGF‐induced angiogenesis and vascular hyperpermeability

Catalog

Books, media, physical & digital resources